Mammary tumors in splenectomized rats

Oncology Reports

Volumn 9, Issue 1, 2002, Pages 185-188

  Kossoy, George ^a   Ben Hur, Herzl ^b   Lifschitz, Oscar ^b   Zusman, Itshak ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Mammary gland tumors; Splenectomy; T lymphocytes

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CARCINOGEN;

ANIMAL; ARTICLE; CELLULAR IMMUNITY; EXPERIMENTAL NEOPLASM; FEMALE; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; NATURAL KILLER CELL; PHYSIOLOGY; RAT; RAT STRAIN; SPLEEN; SPLENECTOMY; T LYMPHOCYTE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; CARCINOGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; IMMUNE SYSTEM; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; MAMMARY NEOPLASMS, EXPERIMENTAL; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; SPLENECTOMY; SUPPORT, NON-U.S. GOV'T;

EID: 0036134191     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.1.185     Document Type: Article

References (15)

1. Shoenfeld Y: Kaleidoscopic autoimmunity. Harefuah 135: 262-264, 1998.
2. Garcia SJ, Prieto A, Reyes E, Manzano L, Merino JL and Alvarez MM: Severe chronic autoimmune thrombocytopenic purpura is associated with an expansion of CD56 positive CD3 negative natural killer cells subset. Blood 82: 1538-1545, 1993. (Pubitemid 23263971)
3. Petroianu A and Antunes LJ: Immune profiles in hepatosplenic schistosomiasis mansoni after surgical treatments. J Int Med Res 26: 43-49, 1998. (Pubitemid 28066179)
4. Mikhailova ZM, Gafarov O, Leontev AF and Chistova LV: The effect of splenectomy on the immune status of children with active liver cirrhosis. Vestnik Khirurgii 148: 61-64, 1992.
5. Kreuzfelder E, Obertacke U, Erhard J, Funk R, Steinen R, Scheiermann N, Thraenhart O, Eigler FW and Schmit-Neuerburg KP: Alterations of the immune system following splenectomy in childhood. J Trauma 31: 358-364, 1991.
6. Mellemkjaer L, Olsen JH, Linet MS, Gridley G and McLaughlin JK: Cancer risk after splenectomy. Ugeskr Laeger 157: 5097-5100, 1995.
7. Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, Ohashi Y and Nakazato H: Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Surg Today 29: 504-510, 1999. (Pubitemid 29313959)
8. Donin N, Sinai J, Michowitz M, Hiss J, Nordenberg J and Leibovici J: Role of immune response as determinant of tumor progression in function of host age in the B16 melanoma. Mech Ageing Dev 80: 121-137, 1995.
9. Soda K, Kawakami M, Takagi S, Kashii A and Miyata M: Splenectomy before tumor inoculation prolongs the survival time of cachectic mice. Cancer Immunol Immunother 41: 203-209, 1995.
10. Kossoy G, Parfenov Y and Turusov V: Carcinogenic effect of benz(a)pyrene depending on the conditions of its application to the skin in mice. Exp Oncol 4: 23-26, 1988.
11. Ge Y, Gao H and Kong XT: Immunoglobulins and complement in splenectomized and autotransplanted subjects. Ann Med 21: 265-267, 1989. (Pubitemid 19238909)
12. Tuttle TM, Anderson BW, Thompson WE, Lee JE, Sahin A, Smith TL, Grabstein KH, Wharton JT, Ioannides CG and Murray JL: Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients. Clin Cancer Res 4: 2015-2024, 1998. (Pubitemid 28369189)
13. Schroder W, Vering A, Stegmuller M and Strolmeier R: Lymphocyte subsets in patients with ovarian and breast cancer. Eur J Gynaecol Oncol 18: 474-477, 1997. (Pubitemid 27519412)
14. Schondorf T, Engel H, Kurbacher CM, Brenne U, Kolhagen H, Gobring UJ, Scharl A and Mallmann P: Immunologie features of tumor-infiltrating lymphocytes and peripheral blood lymphocytes in ovarian cancer patients. J Soc Gynecol Invest 5: 102-107, 1998. (Pubitemid 28099769)
15. Lores B, Garcia-Estevez JM and Arias C: Lymph nodes and human tumors (Review). Int J Mol Med 1: 729-733, 1998.